Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-08

Clinical Trial Update: Corheart 6 LVAS Study [NA]

View source ↗

Summary

ClinicalTrials.gov shows the Corheart 6 LVAS Study for refractory heart failure is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Shenzhen Core Medical Technology CO.,LTD. | Conditions: Refractory Heart Failure | NA | Status: RECRUITING